Alnylam Pharmaceuticals (ALNY)
|
24.82
+0.98 (+4.11%)
|
|
|
|
ALNY analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ALNY price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
ALNY earnings
Date
Actual
Expected
Prev Yr Qtr
11/5/2012
-0.38
-0.31
-0.31
8/6/2012
-0.25
-0.19
-0.33
5/3/2012
-0.25
-0.36
-0.38
Alnylam Pharmaceuticals (ALNY) Upgrades
Date
Analyst
Old Rating
New Rating
02/25/2009
Needham & Co
Underperform
Hold
09/11/2007
Cantor Fitzgerald
Hold
Buy
Alnylam Pharmaceuticals (ALNY) Downgrades
Date
Analyst
Old Rating
New Rating
03/03/2008
Needham & Co
Strong Buy
Underperform
10/10/2007
Piper Jaffray & Co.
Outperform
Market Perform
09/19/2007
Caris & Company
Above Average
Average
08/13/2007
Needham & Co
Buy
Hold
11/03/2006
Bear Stearns
Peer Perform
Outperform
Alnylam Pharmaceuticals (ALNY) New Coverage
Date
Analyst
Rating
05/08/2012
JPMorgan
Overweight
05/20/2010
ThinkEquity
Buy
06/10/2009
Roth Capital
Buy
06/10/2009
Jefferies & Co
Buy
09/12/2008
Thomas Weisel
Marketweight
09/12/2008
Thomas Weisel
Market Weight
